| Peginterferon α‐2a and ribavirin treatment of patients with haemophilia and hepatitis C virus infection: a single‐centre study of 367 cases SM Alavian, SV Tabatabaei, M Keshvari, B Behnava, SM Miri, ... Liver International 30 (8), 1173-1180, 2010 | 60 | 2010 |
| Economic burden of hepatitis B virus-related diseases: evidence from iran K Keshavarz, A Kebriaeezadeh, SM Alavian, AA Sari, FA Dorkoosh, ... Hepatitis monthly 15 (4), e25854, 2015 | 59 | 2015 |
| Development and validation of a simple, rapid and inexpensive PCR-RFLP method for genotyping of common IL28B polymorphisms: a useful pharmacogenetic tool for prediction of … H Sharafi, A Pouryasin, SM Alavian, B Behnava, M Keshvari, ... Hepatitis monthly 12 (3), 190, 2012 | 52 | 2012 |
| Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia SM Alavian, SM Miri, M Keshvari, PK Elizee, B Behnava, SV Tabatabaei, ... Transfusion 49 (10), 2195-2199, 2009 | 46 | 2009 |
| Hepatitis A virus and hepatitis E virus seroprevalence among blood donors in Tehran, Iran K Hesamizadeh, H Sharafi, H Keyvani, SM Alavian, ANT Shabankareh, ... Hepatitis monthly 16 (1), e32215, 2016 | 45 | 2016 |
| Distribution of IL28B genotypes in Iranian patients with chronic hepatitis C and healthy individuals H Sharafi, A Pouryasin, SM Alavian, B Behnava, M Keshvari, S Salimi, ... Hepatitis Monthly 12 (12), e8387, 2012 | 38 | 2012 |
| Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013 M Keshvari, H Sharafi, SM Alavian, H Mehrabadi, S Zolfaghari Transfusion and Apheresis Science 53 (1), 38-47, 2015 | 36 | 2015 |
| WITHDRAWN: Low dose ribavirin for treatment of HCV infected thalassemia major patients: New indications for combination therapy SV Tabatabaei, SM Alavian, M Keshvari, B Behnava, SM Miri, PK Elizee, ... Journal of Hepatology, 2010 | 33 | 2010 |
| Distribution of hepatitis C virus genotypes in iranian patients with congenital bleeding disorders M Keshvari, SM Alavian, B Behnava, SM Miri, EP KARIMI, SV Tabatabaei, ... IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ) 12 (6), 608-614, 2010 | 33 | 2010 |
| Predicting response to HBV vaccination in people with positive anti-HBc but negative HBsAg and anti-HBs A Kabir, SM Alavian, AH Faghihi Kashani, M Keshvari Human vaccines 4 (5), 379-383, 2008 | 30 | 2008 |
| Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients A Haj-Sheykholeslami, M Keshvari, H Sharafi, A Pouryasin, K Hemmati, ... World Journal of Gastroenterology: WJG 21 (29), 8935, 2015 | 27 | 2015 |
| The impact of IFNL4 rs12979860 polymorphism on spontaneous clearance of hepatitis C; a case-control study H Sharafi, SM Alavian, B Behnava, A Pouryasin, M Keshvari Hepatitis Monthly 14 (10), e22649, 2014 | 26 | 2014 |
| The role of polymorphisms near the IL28B gene on response to peg-interferon and ribavirin in thalassemic patients with hepatitis C B Behnava, H Sharafi, M Keshvari, A Pouryasin, L Mehrnoush, S Salimi, ... Hepatitis monthly 16 (1), e32703, 2016 | 25 | 2016 |
| Comparison of serum hepatitis B virus DNA And HBsAg levels between HBeAg-negative and HBeAg-positive chronic hepatitis B patients M Keshvari, SM Alavian, H Sharafi Jundishapur journal of microbiology 8 (3), e21444, 2015 | 25 | 2015 |
| Efficacy of prolonged treatment with pegylated interferon (Peg-IFN) and ribavirin in thalassemic patients with hepatitis C who relapsed after previous Peg-IFN-based therapy S Sandoughdaran, SM Alavian, H Sharafi, B Behnava, S Salimi, ... Hepatitis monthly 15 (1), e23564, 2015 | 23 | 2015 |
| Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg‐Interferon‐α and Ribavirin in patients with congenital bleeding disorder and … M Keshvari, SM Alavian, B Behnava, A Pouryasin, JC Craig, H Sharafi Journal of clinical laboratory analysis 31 (4), e22063, 2017 | 20 | 2017 |
| The prevalence of hepatitis C virus core amino acid 70 substitution and genotypes of polymorphisms near the IFNL3 gene in Iranian patients with chronic hepatitis C D Kadjbaf, M Keshvari, SM Alavian, A Pouryasin, B Behnava, S Salimi, ... Hepatitis monthly 16 (6), e37011, 2016 | 19 | 2016 |
| Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization M Keshvari, SM Alavian, B Aghaee, B Behnava, M Mahdavi, ... Transfusion Medicine 24 (6), 411-417, 2014 | 18 | 2014 |
| Lipid profiles and hepatitis C viral markers in HCV-infected thalassemic patients SM Alavian, SM Miri, SV Tabatabaei, M Keshvari, B Behnava, PK Elizee, ... Gut and Liver 5 (3), 348, 2011 | 16 | 2011 |
| Frequency of fatty liver and some of its risk factors in asymptomatic carriers of HBV attending the Tehran blood transfusion organization hepatitis clinic SM Alavian, M Ramezani, A Bazzaz, M Azuzabadi Farahani, B Behnava, ... Iranian Journal of Endocrinology and Metabolism 10 (2), 99-106, 2008 | 16 | 2008 |
Seyed Moayed AlavianProfessor of Internal Medicine-Research Center,Middle East Liver Disease Center, tehran, Iranبريد إلكتروني تم التحقق منه على thc.ir